PETITIONS
Starta en petitionbläddra
Meny

To aloud OPDIVO in the UK not just Scotland sooner then a year.

Advanced Squamous NSCLC Trial
In a clinical trial of 272 patients whose advanced squamous NSCLC had spread or grown after treatment with platinum-based chemotherapy, 135 were treated with OPDIVO, 137 were treated with chemotherapy (docetaxel). OPDIVO was shown to reduce the risk of dying by 41% compared to chemotherapy (docetaxel). Half of the patients on OPDIVO were still alive at 9.2 months, compared to 6 months with chemotherapy (docetaxel). OPDIVO will not work for everyone. Individual results may vary

Signera petitionen
Signera petitionen
Du har JavaScript inaktiverat. Utan den skulle vår webbplats inte fungera korrekt.

sekretesspolicy

genom att skriva under accepterar du användarvillkor för Care2
Du kan hantera dina epostabonnemang när som helst.

Har problem med att skriva under detta? Låt oss veta.